Definition
US FDA substance register · UNII 076NU497LZ · registered name DI-(4-TERT-BUTYLCYCLOHEXYL)PEROXYDICARBONATE · single chemical substance
Di(t-butylcyclohexyl) Peroxydicarbonate is the organic compound that conforms to the formula
Cosmetic roles
Safety & regulatory references
Not classified under Korea’s toxic-substance GHS list · existing chemical substance
More data — names, identifiers, properties, test records, literature
Names & identifiers
- CAS No.chemical registry number
- 15520-11-3
- EC No.EU chemical inventory number
- 239-557-1
- DTXSIDUS EPA chemical ID
- DTXSID8065907
- DTXCIDUS EPA compound ID
- DTXCID9034999
- IUPAC
- 1-tert-Butyl-4-{[({[(4-tert-butylcyclohexyl)oxy]carbonyl}peroxy)carbonyl]oxy}cyclohexane
- Molecular formula
- C22H38O6
- Molecular weight
- 398.54 g/mol
What products actually use it for
What the 22 products reported to the US EPA with this ingredient use it for. Products outside cosmetics are included, so the top few rows are its main uses.
- Chemical reaction regulator7
- Catalyst7
- Hardener4
- Film former1
- Solvent1
- Plasticizer1
- Processing aids not otherwise specified1
Source: US EPA CompTox dashboard
Irritation and sensitisation studies
4 skin studies and 1 eye studies are on record.
The studies disagree (the most common conclusion covers 50%), so they do not establish that this ingredient is irritating. These tests are on the raw material itself; irritation at the amount in a finished product is a different question.
See all 5 studies
- SkinIrr2
Skin Irritation · QSAR Predicted - High Frequency of Sensitization
skin sensitisation: in vivo (LLNA) · Screening · according to OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay) according to EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay) according to EPA OPPTS 870.2600 (Skin Sensitisation) - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) equivalent or similar to - SkinSens1
Skin Sensitization · QSAR Predicted - Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) equivalent or similar to other guideline: Fed. Reg. 28 (119), 5582, 1963 (published by the FDA of the USA) and Draize and Kelley (Drug. Cosmet. Industr. 71 (1952) 36) according to
Source: US EPA CompTox dashboard